Sebastian Anastassiou

Sebastian Anastassiou serves as a Board Member at Connective Health since September 2024 and holds the position of Principal and Head of Investments at Nina Capital since June 2020, focusing on investments in health tech innovators. Additionally, Sebastian is a Board Member at Segmed, Inc., EarlySight, and Terapet SA, and acts as a Board Observer for Promptly Health and contextflow. With extensive experience in the health tech sector, Sebastian has contributed to organizations developing innovative solutions, from medical AI to retinal imaging and proton therapy. An accomplished academic, Sebastian earned an MBA from IESE Business School with a concentration in Entrepreneurship & Innovation, a Master of Science in Management of Bioeconomy, Innovation and Governance from The University of Edinburgh, and a Bachelor of Science in Neuroscience from the same institution.